These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16443739)

  • 1. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours.
    Kornprat P; Rehak P; Rüschoff J; Langner C
    J Clin Pathol; 2006 Feb; 59(2):202-6. PubMed ID: 16443739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma.
    Schips L; Zigeuner R; Ratschek M; Rehak P; Rüschoff J; Langner C
    Am J Clin Pathol; 2004 Dec; 122(6):931-7. PubMed ID: 15539386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
    Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
    Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer.
    Oshikiri T; Hida Y; Miyamoto M; Hashida H; Katoh K; Suzuoki M; Nakakubo Y; Hiraoka K; Shinohara T; Itoh T; Kondo S; Katoh H
    Br J Cancer; 2001 Dec; 85(12):1922-7. PubMed ID: 11747335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
    Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
    Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
    Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D
    Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
    Matsubara J; Yamada Y; Hirashima Y; Takahari D; Okita NT; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
    Clin Cancer Res; 2008 May; 14(10):3022-9. PubMed ID: 18483367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of insulin-like growth factor II in female breast cancer as related to established prognostic factors and long-term prognosis.
    Toropainen EM; Lipponen PK; Syrjanen KJ
    Anticancer Res; 1995; 15(6B):2669-74. PubMed ID: 8669844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
    Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of IGF-I and IGF-IR in bladder cancer].
    Xie QX; Lin XC; Zhang MF; Han CX; Guo YH
    Ai Zheng; 2004 Jun; 23(6):707-9. PubMed ID: 15191677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta.
    Koda M; Sulkowski S; Garofalo C; Kanczuga-Koda L; Sulkowska M; Surmacz E
    Horm Metab Res; 2003; 35(11-12):794-801. PubMed ID: 14710360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
    Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
    Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.
    Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB
    Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6-P/IGF 2R).
    Pavelić K; Kolak T; Kapitanović S; Radosević S; Spaventi S; Kruslin B; Pavelić J
    J Pathol; 2003 Nov; 201(3):430-8. PubMed ID: 14595755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local expression of insulin-like growth factor-I, insulin-like growth factor-I receptor, and estrogen receptor alpha in ovarian cancer.
    An Y; Cai L; Wang Y; Zhu D; Guan Y; Zheng J
    Onkologie; 2009 Nov; 32(11):638-44. PubMed ID: 19887867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
    Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma.
    Imsumran A; Adachi Y; Yamamoto H; Li R; Wang Y; Min Y; Piao W; Nosho K; Arimura Y; Shinomura Y; Hosokawa M; Lee CT; Carbone DP; Imai K
    Carcinogenesis; 2007 May; 28(5):947-56. PubMed ID: 17183068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma.
    Sichani MM; Yazdi FS; Moghaddam NA; Chehrei A; Kabiri M; Naeimi A; Taheri D
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):69-74. PubMed ID: 20061696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.